trimetrexate pharmacology

Trimetrexate, a potent dihydrofolate reductase (DHFR) inhibitor, is an antimetabolite chemotherapeutic agent primarily used in the treatment of Pneumocystis jirovecii pneumonia (PCP) in immunocompromised patients,…